Kymera Therapeutics, Inc.

Q3 2021 13F Holders

Symbol
KYMR
CUSIP
501575104
Type
Equity
Class
COM
Num filers
118
Total reported value, excl. options
$2.04B
Manager Report Date Value ($000) Shares Option Type